Cefaloridine is a first-generation semisynthetic derivative of cephalosporin C. It is unique among cephalosporins in that it exists as a zwitterion. Cephaloridine was very effective to cure pneumococcal pneumonia. It has a high clinical and bacteriologica
Albocycline is a Macrolide antibiotic from Streptomyces bruneogriseus nov. sp. MCRL-0129; specifically anti-staphylococcal, including antibiotic-resistant strains.
Ristocetin is an antibiotic isolated from Amycolatopsis lurida that is previously used to the treatment of staphylococcal infections. It is no longer used clinically because it caused thrombocytopenia and platelet agglutination.
Ristocetin A, a glycopeptide related to vancomycin, is an antibiotic produced by the microorganism Nocardia lurida[1].
Ristocetin A is currently in clinical use to treat bacterial infections [1]. Ristocetin A is an antibiotic which can be used to treat staphylococcal infections. The side effects of ristocetin A include thrombocytopenia and platelet agglutination. Ristocetin A has been used in two assays: the ristocetin cofactor assay and the ristocetin-induced platelet aggregation assay. These two assays could be used to diagnosis the von Willebrand disease and other bleeding disorders [2, 3]. The structural features of Ristocetin A are similar to vancomycin.
Naptumomab是一种由抗5T4癌胚抗原的Fab片段与改良型葡萄球菌肠毒素A(SEA/E-120)组成的肿瘤靶向超抗原(TTS)融合蛋白。Naptumomab通过 Fab 段特异性识别多种实体瘤表面表达的5T4蛋白,并利用超抗原成分强效激活T细胞(主要通过与 TCR Vβ链结合),诱导T细胞介导的细胞毒性作用来杀伤肿瘤细胞。Naptumomab能绕过主要组织相容性复合体(MHC)限制,直接招募并激活大量效应T细胞进入肿瘤微环境。